ELISA protocols are easy to perform, take very little time to perform, and have high sensitivity and specificity for monitoring changes in the levels of tumor markers such as CEA (carcinoembryonic antigen) and CA19‐9 [30], which may be associated with tumor recurrence, metastasis, or response to treatment. This evidence concerns the gene CEACAM5 and neoplasm.